MC Alessi, I Juhan-Vague - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc The link between plasminogen activator inhibitor (PAI)-1 and the metabolic
syndrome with obesity was established many years ago. Increased PAI-1 level can
be now considered a true component of the syndrome. The metabolic syndrome ... Cited by 106 - Related articles - All 9 versions
- ►nursing2008.com MC Alessi, M Poggi, I Juhan-Vague - Current opinion in lipidology, 2007 - journals.lww.com Purpose of review Plasminogen activator inhibitor (PAI)-1 is a physiological
inhibitor of plasminogen activators (urokinase and tissue types) and
vitronectin. It is synthesized by adipose tissue, and its levels in plasma ... Cited by 32 - Related articles - BL Direct - All 7 versions
- ►nursing2008.com PA Jansson - Journal of internal medicine, 2007 - pt.wkhealth.com Macrovascular disease is the number one killer in type 2 diabetes patients. The
cluster of risk factors in the insulin resistance syndrome (IRS) partly explains
this notion. Insulin action in muscle, liver or adipose tissue has been ... Cited by 31 - Related articles - BL Direct - All 7 versions
JB Meigs, MG Larson, CS Fox, JF Keaney, RS … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We used cross-sectional data from 2,002
nondiabetic subjects of the community-based Framingham Offspring Study. We
measured insulin resistance with the homeostasis model and defined ... Cited by 28 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org D Conen, PM Ridker, S Mora, JE Buring, RJ … - European heart journal, 2007 - Eur Soc Cardiology Methods and results: We performed a prospective cohort study among 38 172 women
free of diabetes and cardiovascular disease at baseline. Women were classified
into four categories according to self-reported baseline BP (<120/75 mmHg, ... Cited by 27 - Related articles - BL Direct - All 10 versions
M Diamant, ME Tushuizen - Current Diabetes Reports, 2006 - Springer Due to global lifestyle changes, obesity (the main driver of type 2 diabetes
[T2D] and cardiovascular disease [CVD]) is reaching pandemic proportions. The
metabolic syndrome, which is regarded as a prediabetic state, is ... Cited by 19 - Related articles - BL Direct - All 2 versions
MC Alessi, I Juhan-Vague - Thrombosis and haemostasis, 2008 - ncbi.nlm.nih.gov The metabolic syndrome (metS), a concurrence of abdominal fat, disturbed glucose
and insulin metabolism, dyslipidemia, and hypertension has been strongly
associated not only with subsequent development of type 2 diabetes but also ... Cited by 16 - Related articles - BL Direct - All 3 versions
- Free from Publisher M Dysfunction, CDA Stehouwer - Physiology, 2007 - sochob.cl Evidence from several studies indicates that obesity impairs microvascular
function in several ways. First, impairments of endothelial function of
different microvascular structures have been demonstrated in obesity. Obese ... Cited by 14 - Related articles - View as HTML - BL Direct - All 6 versions
- ►ahajournals.org [PDF] PE Morange, N Saut, MC Alessi, JS Yudkin, … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2007 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Association of Plasminogen Activator ... Cited by 13 - Related articles - All 8 versions
